BRPI0506493A - combinações terapêuticas - Google Patents

combinações terapêuticas

Info

Publication number
BRPI0506493A
BRPI0506493A BRPI0506493-7A BRPI0506493A BRPI0506493A BR PI0506493 A BRPI0506493 A BR PI0506493A BR PI0506493 A BRPI0506493 A BR PI0506493A BR PI0506493 A BRPI0506493 A BR PI0506493A
Authority
BR
Brazil
Prior art keywords
therapeutic combinations
relates
present
administering
animal
Prior art date
Application number
BRPI0506493-7A
Other languages
English (en)
Inventor
Jennifer Lou Hammond
Amy Karen Patick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0506493A publication Critical patent/BRPI0506493A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMBINAçõES TERAPêUTICAS". A presente invenção refere-se a métodos para o tratamento de uma infecção por HIV de um mamífero por administração ao animal de uma quantidade terapeuticamente eficaz de uma combinação de compostos. A presente invenção também refere-se a composições compreendendo certos compostos úteis como inibidores da enzima de protease de HIV e pelo menos um agente terapêutico adicional.
BRPI0506493-7A 2004-01-30 2005-01-17 combinações terapêuticas BRPI0506493A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54074904P 2004-01-30 2004-01-30
US61500004P 2004-10-01 2004-10-01
PCT/IB2005/000101 WO2005082362A1 (en) 2004-01-30 2005-01-17 Therapeutic combinations

Publications (1)

Publication Number Publication Date
BRPI0506493A true BRPI0506493A (pt) 2007-02-13

Family

ID=34915540

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506493-7A BRPI0506493A (pt) 2004-01-30 2005-01-17 combinações terapêuticas

Country Status (12)

Country Link
US (1) US20050171038A1 (pt)
EP (1) EP1713470A1 (pt)
JP (1) JP2007519704A (pt)
KR (1) KR20060114374A (pt)
AU (1) AU2005216710A1 (pt)
BR (1) BRPI0506493A (pt)
CA (1) CA2555171A1 (pt)
IL (1) IL177155A0 (pt)
MX (1) MXPA06008632A (pt)
NO (1) NO20063483L (pt)
RU (1) RU2006128606A (pt)
WO (1) WO2005082362A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2584670A1 (en) * 2004-10-19 2006-04-27 Achillion Pharmaceuticals, Inc. Combination therapy for treating viral infections
JP2008533017A (ja) * 2005-03-11 2008-08-21 スミスクライン ビーチャム コーポレーション Ｈｉｖプロテアーゼ阻害薬
WO2007033208A2 (en) * 2005-09-12 2007-03-22 University Of Maryland Biotechnology Institute Off. Of Research Admin/Tech. Dev. Use of indirubin and its derivatives in the treatments of hiv infection and heart failure
FR2892719B3 (fr) * 2005-11-02 2008-01-18 Sep Innovaterm Barriere physico-chimique anti-termites constituee par du beton dans lequel a ete incorpore dans toute la masse un insecticide contre les termites
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
CA2651943C (en) * 2006-03-02 2015-06-30 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
WO2008011116A2 (en) * 2006-07-21 2008-01-24 Gilead Sciences, Inc. Aza-peptide protease inhibitors
CA2664118A1 (en) * 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
WO2013071353A1 (en) * 2011-11-18 2013-05-23 Avexa Limited Apricitabine and pi combination therapy
CN105669749B (zh) * 2014-08-14 2018-03-30 赫斯（西安）生物科技有限公司 抗病毒药物及组合物
WO2019002228A1 (en) * 2017-06-26 2019-01-03 Institut Pasteur TREATMENTS TO REMOVE HIV RESERVOIRS AND REDUCE VIRAL LOAD

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2002000136A (es) * 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis

Also Published As

Publication number Publication date
CA2555171A1 (en) 2005-09-09
RU2006128606A (ru) 2008-03-10
WO2005082362A1 (en) 2005-09-09
IL177155A0 (en) 2008-04-13
KR20060114374A (ko) 2006-11-06
JP2007519704A (ja) 2007-07-19
NO20063483L (no) 2006-08-30
EP1713470A1 (en) 2006-10-25
MXPA06008632A (es) 2006-09-04
US20050171038A1 (en) 2005-08-04
AU2005216710A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
AR060089A1 (es) Tratamiento del dolor
MX2022015812A (es) Inhibidores de cisteina proteasas y sus metodos de uso.
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
DOP2002000438A (es) Inhibidores de la dipetidil peptidasa beta-amino heterocíclica para el tratamiento o la prevención de la diabetes
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
BRPI0415167A (pt) composto de amina como ligandos de canal de ìon e usos dos mesmos
EA200802166A1 (ru) Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
BR0009167A (pt) Inibidores de enzima impdh
GT200800184A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
EA200900663A1 (ru) Лечение синдрома "сухого глаза"
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BR0310092A (pt) Combinação de compostos orgânicos
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
BRPI0607897A2 (pt) compostos oxindol e sua utilização como agentes terapêuticos
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
EP1819227A4 (en) PHARMACEUTICAL FORMULATIONS OF DECITABIN
BRPI1015539A2 (pt) composições e métodos para tratamento de queimaduras
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
BRPI0506493A (pt) combinações terapêuticas
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
BRPI0509074A (pt) composições farmacêuticas compreendendo agonistas do receptor da tiróide
EP1543158A4 (en) REGULATED APTAMER THERAPEUTICS
BR0312768A (pt) Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos
BR0308184A (pt) Composição oftálmica compreendendo ascomicina
WO2022192594A3 (en) Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A E 6A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011.